Can-Fite BioPharma

CANFNYSE Israel Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$7.370 M

$3.44 -3.37%

Close of 7 Aug 2026

Revenue

$405.0K

#3565 by revenue

Earnings

-$9.83M

Loss-making

Shares outstanding

2,618,425

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#448MetaViaMTVA$7.69M
#449BiovieBIVI$7.54M
#450Can-Fite BioPharmaCANF$7.37M
#451Addex TherapeuticsADXN$7.34M
#452Xenetic BiosciencesXBIO$7.26M

Where these numbers come from

Share counts and financials for Can-Fite BioPharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.